Despite Elite Rating, Huge Sales, Expanded Pfizer Still Faces Challenges.

Knight Ridder/Tribune Business News,  May, 2003  

Tags: Hartford Courant, Matthew, Pfizer Inc., sales

• E-mail
• Print
• Link

By Matthew Lubanko, The Hartford Courant, Conn. Knight Ridder/Tribune Business News

May 4--Despite spending tens of billions of dollars to buy two companies over the last three years, Pfizer Inc. still retains an elite Triple-A credit rating.

That Triple-A rating places Pfizer in a select club with just seven other U.S. companies. The drug-maker employs 6,000 in the Groton-New London area of Connecticut.

But that Triple-A rating only assures bondholders that Pfizer can make good on its debts. It does not suggest that investors should run out and buy Pfizer stock -- and ...

Read the rest of this article with a Free Trial at HighBeam Research.